The global minimally invasive cardiac surgery instruments market is estimated to grow at a CAGR of around 9.1% during the forecast period. The major factors contributing to the growth of the market include increasing demand for minimally invasive cardiac procedures and technological innovations in minimally invasive cardiac devices. There are several benefits associated with minimally invasive cardiac surgery as smaller incisions are involved in it. Moreover, it includes shorter hospital stays (generally 2-5 days), minimal risk of bleeding and infection, less scarring and pain and shorter recovery time. In addition, the increasing number of cardiac surgeries has reported over the last decade. For instance, according to Pennsylvania Healthcare Cost Containment Council, in Pennsylvania (the US state), the valve procedures were significantly increased with 11.3% from 6,643 to 7,396 during the period (2005 to 2015).
Moreover, according to the annals of thoracic surgery, during the period (January 2013 to December 2014), there were complete in-hospital data which includes 46,303 procedures that are submitted to the database. China is undergoing a significant demand for cardiac surgeries. There are two hospitals have a volume of over 10,000 cases per year, however, over 70% of places have a volume with less than 2000 cases every year which includes congenital cardiac surgeries. This rise in cardiac surgeries is expected to fuel the demand for minimally invasive cardiac surgeries that ultimately leads to propel the adoption of advanced minimally invasive surgical devices such as THVT.
The major players operating the market include Abbott Laboratories, Inc., Edwards Lifesciences Corp., Boston Scientific Corp., Medtronic plc, and Intuitive Surgical, Inc. These companies are involved in the manufacturing of artificial vales, drug-eluting stents, guidewires and balloon devices. Moreover, increasing FDA approvals for their devices has been supporting healthcare providers to offer effective care to the patients. For instance, in March 2018, the FDA approved the Masters HP 15mm rotatable mechanical heart valve (Abbott Laboratories). It is the world’s first and only smallest mechanical heart valve that will enable doctors for the treatment of toddlers and babies who require aortic or mitral valve replacement.
Research Methodology
The market study of the global minimally invasive cardiac surgery instruments market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include:
The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Abbott Laboratories, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Edwards Lifesciences Corp.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Boston Scientific Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Medtronic plc
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Intuitive Surgical, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Minimally Invasive Cardiac Surgery Instruments Market by Product
5.1.1. Inflation Systems
5.1.2. Cutter Instruments
5.1.3. Guiding Devices
5.1.4. Handheld Instruments
5.1.5. Stents
5.1.6. Sutures
5.1.7. Monitoring and Visualization Equipment
5.1.8. Robotic-Assisted Surgical Systems
5.1.9. Others (Implantable Cardioverter Defibrillator and Permanent Pacemaker)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Applied Medical Resources Corp.
7.3. B. Braun Melsungen AG
7.4. Boston Scientific Corp.
7.5. Cordis Corp.
7.6. Edwards Lifesciences Corp.
7.7. General Electric Co.
7.8. Intuitive Surgical, Inc.
7.9. Johnson & Johnson Services, Inc.
7.10. Koninklijke Philips N.V.
7.11. LivaNova PLC
7.12. Medtronic plc
7.13. Olympus Corp.
7.14. Teleflex, Inc.
7.15. Terumo Corp.
1. GLOBAL MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
2. GLOBAL INFLATION SYSTEMS FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL CUTTER INSTRUMENTS FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL GUIDING DEVICES FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL HANDHELD INSTRUMENTS FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL STENTS FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL SUTURES FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL MONITORING AND VISUALIZATION EQUIPMENT FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL ROBOTIC-ASSISTED SURGICAL SYSTEMS FOR MINIMALLY INVASIVE CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL OTHER MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
12. NORTH AMERICAN MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
13. NORTH AMERICAN MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
14. EUROPEAN MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
15. EUROPEAN MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
16. ASIA-PACIFIC MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
17. ASIA-PACIFIC MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
18. REST OF THE WORLD MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
1. GLOBAL MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
2. GLOBAL MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
3. US MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
4. CANADA MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
5. UK MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
6. FRANCE MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
7. GERMANY MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
8. ITALY MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
9. SPAIN MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
10. ROE MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
11. INDIA MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
12. CHINA MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
13. JAPAN MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
14. REST OF ASIA-PACIFIC MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF THE WORLD MINIMALLY INVASIVE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2025 ($ MILLION)